BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11955406)

  • 21. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.
    Span PN; Waanders E; Manders P; Heuvel JJ; Foekens JA; Watson MA; Beex LV; Sweep FC
    J Clin Oncol; 2004 Feb; 22(4):691-8. PubMed ID: 14966093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
    Ferrucci PF; Rabascio C; Mazzetta C; Cocorocchio E; Agazzi A; Vanazzi A; Cinieri S; Peccatori FA; Paolucci M; Bertolini F; Martinelli G
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6039-46. PubMed ID: 15447988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammaglobin, a potential marker of breast cancer nodal metastasis.
    Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH
    J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients.
    Lin YC; Chen SC; Hsueh S; Lo YF; Chow-Wu YH; Liaw IC; Cheng AJ
    Cancer Sci; 2003 Jan; 94(1):99-102. PubMed ID: 12708482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of small breast epithelial mucin mRNA in peripheral blood of breast cancer patients and its clinical significance].
    Yang HW; Cao J; Yang NW; Liu JL; Zhang CM; Chen JS; Hong JS; Jiang Y; Su JJ
    Ai Zheng; 2005 Jul; 24(7):842-5. PubMed ID: 16004812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
    Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
    Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
    Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
    Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction.
    Leone F; Perissinotto E; Viale A; Cavalloni G; Taraglio S; Capaldi A; Piacibello W; Torchio B; Aglietta M
    Bone Marrow Transplant; 2001 Mar; 27(5):517-23. PubMed ID: 11313686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
    Ignatiadis M; Kallergi G; Ntoulia M; Perraki M; Apostolaki S; Kafousi M; Chlouverakis G; Stathopoulos E; Lianidou E; Georgoulias V; Mavroudis D
    Clin Cancer Res; 2008 May; 14(9):2593-600. PubMed ID: 18451221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C; Hu L; Xia L; Li Y
    Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers.
    Lin YC; Wu Chou YH; Liao IC; Cheng AJ
    Cancer Lett; 2003 Feb; 191(1):93-9. PubMed ID: 12609714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
    Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
    Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics.
    Silva JM; Dominguez G; Silva J; Garcia JM; Sanchez A; Rodriguez O; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2001 Sep; 7(9):2821-5. PubMed ID: 11555599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
    Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
    Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
    Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
    J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA.
    Zach O; Kasparu H; Krieger O; Hehenwarter W; Girschikofsky M; Lutz D
    J Clin Oncol; 1999 Jul; 17(7):2015-9. PubMed ID: 10561252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
    Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical research on angiogenesis in colorectal carcinoma and expression of CK20 mRNA in peripheral blood].
    Xu Q; Chen RX; Wang ZW; Ni QC; Qian JJ; Sheng HX
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1205-8. PubMed ID: 16029598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
    Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.